Hong Kong SAR, China: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Hong Kong SAR, China

In 2022, the Hong Kong market for other medicaments for therapeutic or prophylactic uses was finally on the rise to reach $X after two years of decline. Over the period under review, consumption recorded a deep reduction. Over the period under review, the market hit record highs at $X in 2012; however, from 2013 to 2022, consumption stood at a somewhat lower figure.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Hong Kong SAR, China

In value terms, production of other medicaments for therapeutic or prophylactic uses fell rapidly to $X in 2022 estimated in export price. Overall, production showed a significant contraction. The growth pace was the most rapid in 2016 when the production volume increased by X%. As a result, production reached the peak level of $X. From 2017 to 2022, production of growth remained at a lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Hong Kong SAR, China

In 2022, approx. X tons of other medicaments for therapeutic or prophylactic uses were exported from Hong Kong SAR; falling by X% against the previous year's figure. In general, exports continue to indicate a precipitous slump. The pace of growth was the most pronounced in 2021 when exports increased by X%. Over the period under review, the exports of hit record highs at X tons in 2012; however, from 2013 to 2022, the exports remained at a lower figure.

In value terms, exports of other medicaments for therapeutic or prophylactic uses totaled $X in 2022. Over the period under review, exports continue to indicate a dramatic slump. The most prominent rate of growth was recorded in 2021 when exports increased by X% against the previous year. The exports peaked at $X in 2012; however, from 2013 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

Macao SAR (X tons) was the main destination for exports of other medicaments for therapeutic or prophylactic uses from Hong Kong SAR, accounting for a X% share of total exports. Moreover, exports of other medicaments for therapeutic or prophylactic uses to Macao SAR exceeded the volume sent to the second major destination, the Philippines (X kg), more than tenfold.

From 2012 to 2022, the average annual rate of growth in terms of volume to Macao SAR stood at X%.

In value terms, Macao SAR ($X) emerged as the key foreign market for other medicaments for therapeutic or prophylactic uses exports from Hong Kong SAR, comprising X% of total exports. The second position in the ranking was held by the Philippines ($X), with a X% share of total exports.

From 2012 to 2022, the average annual growth rate of value to Macao SAR stood at X%.

Export Prices by Country

The average export price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, growing by X% against the previous year. In general, the export price saw a resilient expansion. As a result, the export price attained the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices for the major overseas markets. In 2022, amid the top suppliers, the country with the highest price was the Philippines ($X per ton), while the average price for exports to Macao SAR totaled $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Macao SAR (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Hong Kong SAR, China

In 2022, the amount of other medicaments for therapeutic or prophylactic uses imported into Hong Kong SAR rose to X tons, increasing by X% on the previous year's figure. In general, imports, however, showed a sharp downturn. The most prominent rate of growth was recorded in 2019 when imports increased by X% against the previous year. Imports peaked at X tons in 2012; however, from 2013 to 2022, imports remained at a lower figure.

In value terms, imports of other medicaments for therapeutic or prophylactic uses surged to $X in 2022. Overall, imports, however, saw a deep reduction. The most prominent rate of growth was recorded in 2019 when imports increased by X%. Imports peaked at $X in 2012; however, from 2013 to 2022, imports failed to regain momentum.

Imports by Country

In 2022, China (X tons) constituted the largest other medicaments for therapeutic or prophylactic uses supplier to Hong Kong SAR, with a X% share of total imports. It was followed by Malaysia (X tons), with a X% share of total imports. The third position in this ranking was held by the United States (X tons), with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from China stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: Malaysia (X% per year) and the United States (X% per year).

In value terms, China ($X) constituted the largest supplier of other medicaments for therapeutic or prophylactic uses to Hong Kong SAR, comprising X% of total imports. The second position in the ranking was held by the United States ($X), with a X% share of total imports. It was followed by Ireland, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value from China amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: the United States (X% per year) and Ireland (X% per year).

Import Prices by Country

The average import price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, rising by X% against the previous year. In general, import price indicated resilient growth from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, import price for other medicaments for therapeutic or prophylactic uses increased by X% against 2018 indices. As a result, import price attained the peak level and is likely to continue growth in the immediate term.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was China ($X per ton), while the price for Malaysia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Italy (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :